Affimed (AFMD)
(Delayed Data from NSDQ)
$3.96 USD
-0.06 (-1.49%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $3.96 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AFMD 3.96 -0.06(-1.49%)
Will AFMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AFMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AFMD
Affimed Appoints New CEO, Shares Fall on Leadership Change
Oculis Holding AG (OCS) Reports Q2 Loss, Misses Revenue Estimates
AFMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates
Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
Other News for AFMD
Truist Financial Keeps Their Buy Rating on Affimed (AFMD)
Affimed to Present at the Cantor Global Healthcare Conference 2024
Affimed NV (AFMD) Q2 2024 Earnings Call Transcript Highlights: Financials, Clinical Progress, ...
Affimed N.V. (AFMD) Q2 2024 Earnings Call Transcript
Affimed N.V. 2024 Q2 - Results - Earnings Call Presentation